Can-Fite BioPharma Ltd. Quarterly Liabilities, Current in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
Can-Fite BioPharma Ltd. quarterly Liabilities, Current history and growth rate from Q4 2018 to Q4 2023.
  • Can-Fite BioPharma Ltd. Liabilities, Current for the quarter ending December 31, 2023 was $2.02M, a 19.3% decline year-over-year.
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $2.02M -$482K -19.3% Dec 31, 2023 20-F 2024-03-28
Q2 2023 $2.23M +$80K +3.72% Jun 30, 2023 6-K 2023-08-31
Q4 2022 $2.5M -$228K -8.35% Dec 31, 2022 20-F 2024-03-28
Q2 2022 $2.15M -$206K -8.73% Jun 30, 2022 6-K 2022-08-25
Q4 2021 $2.73M +$1.46M +115% Dec 31, 2021 20-F 2023-03-30
Q2 2021 $2.36M +$858K +57.2% Jun 30, 2021 6-K 2021-08-26
Q4 2020 $1.27M -$2M -61.2% Dec 31, 2020 20-F 2022-03-24
Q2 2020 $1.5M Jun 30, 2020 6-K 2020-08-27
Q4 2019 $3.27M +$152K +4.87% Dec 31, 2019 20-F 2021-03-25
Q4 2018 $3.12M Dec 31, 2018 6-K 2020-06-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.